新検索ページはこちら
ログイン
お問い合わせ
（旧版）高血圧治療ガイドライン2004
書誌情報
文献
| 401 ） | 内山聖，菊池透，山内邦昭，村田光範：わが国における高血圧の基準値の妥当性と問題点．小児保健研究（印刷中）. |
| 402 ） | Abe K, Nishio T, Mori C, Haneda N, Watanabe K: A longitudinal study of blood pressure, cholesterol and left ventricular muscle volume in children: The Shimane Heart Study. Acta Paediatr Jpn 1993; 35: 130-137. |
| 403 ） | Daniels SR, Witt SA, Glascock B, Khoury PR, Kimball TR: Left atrial size in children with hypertension: the influence of obesity, blood pressure, and left ventricular mass. J Pediatr 2002; 141: 186-190. |
| 404 ） | Uchiyama M: Risk factors for the development of essential hypertension: long-term follow-up study in junior high school students in Niigata, Japan. J Hum Hypertens 1994; 8: 323-325. |
| 405 ） | Kawasaki T, Uezono K, Sanefuji M, Utsunomiya H, Fujino T, Kanaya S, Babazono A: A 17-year follow-up study of hypertensive and normotensive male university students in Japan. Hypertens Res 2002; 26: 445-452. |
| 406 ） | Geleijnse JM, Hofman A, Witteman JCM, Hazebroek AA, Valkenburg HA, Grobbee DE: Long-term effects of neonatal sodium restriction on blood pressure. Hypertension 1997; 29: 913-917. |
| 407 ） | Martin RM, Ness AR, Gunnell SA, Emmett P, Smith GD: Does breastfeeding in infancy lower blood pressure in childhood? The Avon Longitudinal Study of Parents and Children（ALSPAC）. Circulation 2004; 109: 1259-1266. |
| 408 ） | Research Committee on Serum Lipid Level Survey 1990 in Japan: Current state of and recent trends in serum lipid levels in the general Japanese population. J Atherosclerosis and Thrombosis 1996; 2: 122-132. |
| 409 ） | Weiss R, Dziura J, Burgert T, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-2374. |
| 410 ） | Kotani K, Nishida M, Yamashita S, Funahashi T, Fujioka S, Tokunaga K, Ishikawa K, Tarui S, Matsuzawa Y: Two decades of annual medical examinations in Japanese obese children: do obese children grow into obese adults? Internat J Obes Related Metab Disord 1997; 21: 912-921. |
| 411 ） | 長沼賢寛，富沢修一，五十嵐宏三，遠山潤，小澤寛二，内山聖：小児肥満における24時間血圧測定の有用性について．小児科診療 1996; 59: 2084-2088. |
| 412 ） | 富沢修一，内山聖，倉山英昭，高橋昌里，栖原優，門脇純一，酒井糾：小児腎疾患に伴う高血圧に対するニフェジピン持効性細粒剤（セパミットR細粒）の投与量の検討．小児科診療 1996; 59: 303-310. |
| 413 ） | Ingelfinger JR: When should essential hypertension in childhood be treated and how? Pediatr Nephrol 1995; 9: 552. |
| 414 ） | Gifford RW: Evaluation of the hypertensive patient with emphasis on detecting curable causes. Milbank Mem Fund Q 1969; 47: 170-186. |
| 415 ） | Bech K, Hilden T: The frequency of secondary hypertension. Acta Med Scand 1975; 197: 65-69. |
| 416 ） | Ferguson RK: Cost and yield of the hypertensive evaluation. Ann Intern Med 1975; 82: 761-765. |
| 417 ） | Berglund G, Andersson O, Wilhelmsen L: Prevalence of primary and secondary hypertension: studies in a random population sample. BMJ 1976; 2: 554-556. |
| 418 ） | Danielson M, Dammstrom BG: The prevalence of secondary and curable hypertension. Acta Med Scand 1981; 209: 451-455. |
| 419 ） | Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JWK: Secondary hypertension in a blood pressure clinic. Arch Intern Med 1987; 147: 1289-1293. |
| 420 ） | Omura M, Saita J, Yamaguchi K, Kakuta Y, Nishikawa T: Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004; 27: 193-202. |
| 421 ） | 尾前照雄：高血圧症の病態と予後．日内会誌 1985; 74: 401-415. |
| 422 ） | Hypertension in Diabetes Study（HDS）: 1. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993; 11: 309-317. |
| 423 ） | Dinneen SF, Gerstein HC: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997; 157: 1413-1418. |
| 424 ） | Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118: 577-581. |
| 425 ） | Ravid M, Brosh D, Levi Z, Bar-dayan Y, Ravid D, Rachmani R: Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1998; 128: 982-988. |
| 426 ） | Bretzel RG: Effects of antihypertensive drugs on renal function in patients with diabetic nephropathy. Am J Hypertens 1997; 10: 208S-217S. |
| 427 ） | Preston RA, Singer I, Epstein M: Renal parenchymal hypertension. Arch Intern Med 1996; 156: 601-611. |
| 428 ） | Nolin L, Courteau M: Management of IgA nephropathy: Evidence-based recommendations. Kidney Int 1999; 55（Suppl 70）: S56-S62. |
| 429 ） | Maschio G, Cagnoli L, Claroni F, Fusaroli M, Rugiu C, Sanna G, Sasdelli M, Zuccala A, Zucchelli P: ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: A multicentre, randomized, placebo-controlled study. Nephrol Dial Transplant 1994; 9: 265-269. |
| 430 ） | 東原英二：常染色体優性多発性嚢胞腎（ADPKD）診療指針．腎臓 2003; 26: 71-81. |
| 431 ） | Mizoguchi M, Tamura T, Yamaki A, Higashihara E, Shimizu Y: Genotypes of autosomal dominant polycystic kidney disease in Japanese. J Hum Genet 2002; 47: 51-54. |
| 432 ） | Higashihara E, Nutahara K, Kojima M, Tamakoshi A, Yoshiyuki O, Sakai H, Kurokawa K: Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron 1998; 80: 421-427. |
| 433 ） | Higashihara E, Aso Y, Shimazaki J, Ito H, Koise K, Sakai O: Clinical aspects of polycystic kidney disease. J Urol 1992; 147: 329-332. |
| 434 ） | Torres VE, Wilson DM, Burnett JC Jr, Johnson CM, Offord KP: Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. Mayo Clin Proc 1991; 66: 1010-1017. |
| 435 ） | Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Chapman AB, Gabow PA, Schrier RW: Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2000; 35: 427-432. |
| 436 ） | 東原英二：多発性嚢胞腎患者に対する降圧剤の腎保護作用に関する研究およびPPARγアゴニストによるADPKD腎不全進展抑制に関する研究．厚生労働省特定疾患，進行性腎障害調査研究班 平成14年度研究報告，2003, pp73-76. |
| 437 ） | Ruggieri PM, Poulos N, Masaryk TJ, Ross JS, Obuchowski NA, Awad IA, Braun WE, Nally J, Lewin JS, Modic MT: Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology 1994; 191: 33-39. |
| 438 ） | Yamashita T, Ito F, Iwakiri N, Mitsuyama H, Fujii S, Kitabatake A: Prevalence and predictors of renal artery stenosis in patients undergoing cardiac catheterization. Hypertens Res 2002; 25: 553-557. |
| 439 ） | Uzu T, Inoue T, Fujii T, Nakamura S, Inenaga T, Yutani C, Kimura G: Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis 1997; 29: 733-738. |
| 440 ） | Preston RA, Epstein M: Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertens 1997; 15: 1365-1377. |
| 441 ） | Tuttle KR: Screening for renal artery stenosis: Hypertension and more. Am J Kidney Dis 1998; 32: 842-847. |
| 442 ） | Imai Y, Abe K, Otsuka Y, Sakurai Y, Ito T, Sato M, Haruyama T, Omata K, Hiwatari M, Yoshinaga K: Exaggerated response of renin secretion to captopril（SQ 14225）in renovascular hypertension. Jpn Heart J 1980; 21: 793-802. |
| 443 ） | Oei HY: Captopril renography. Early observation and diagnostic criteria. Am J Hypertens 1991; 4: 678S-684S. |
| 444 ） | Nally JV, Chen C, Fine E, Fommei E, Ghione S, Geyskes GG, Hoffer PB, Sfakianakis G: Diagnostic criteria of renovascular hypertension with captopril renography. A consensus statement. Am J Hypertens 1991; 4: 749S-752S. |
| 445 ） | Olin JW, Peidmonte MR, Young JR, DeAnna S, Grubb M, Childs MB: The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med 1995; 122: 833-838. |
| 446 ） | Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Martin K, Haller H: Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001; 344: 410-417. |
| 447 ） | Vasbinder GBC, Nelemans PJ, Kessels AGH, Kroon AA, de Leeuw PW, van Engelshoven JMA: Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001; 135: 401-411. |
| 448 ） | Sos TA: Angioplasty for the treatment of azotemia and renovascular hypertension in atherosclerotic renal artery disease. Circulation 1991; 83（Suppl I）: I-162-I-166. |
| 449 ） | Tegtmeyer CJ: Percutaneous renal revascularization. Mayo Clin Proc 1995; 70: 1127-1129. |
| 450 ） | Bonelli FS, McKusick MA, Textor SC, Kos PB, Stanson AW, Johnson CM, Sheedy II AF, Welch TJ, Schirger A: Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc 1995; 70: 1041-1052. |
| 451 ） | Zeller T, Frank U, Muller C, Burgelin K, Sinn L, Bestehorn H-P, Cook-Bruns N, Neumann F-J: Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation 2003; 108:2244-2249. |
| 452 ） | Eardley KS, Lipkin GW: Atherosclerotic renal artery stenosis: is it worth diagnosing? J Hum Hypertens 1999; 13: 217-220. |
| 453 ） | Plouin P-F, Chatellier G, Darne B, Raynaud A, for the Essai Multicentrique Medicaments vs Angioplastie（EMMA）Study Group: Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Hypertension 1998; 31: 823-829. |
| 454 ） | 副島秀久，池上圭一，町田二郎，吉田正貴：腎血管性高血圧症に対する治療法の変遷と予後．日泌尿会誌 1990; 81: 902-908. |
| 455 ） | 一城貫政，山本奈津子，上芝元，宮地幸隆：副腎偶発腫瘍の疫学．ホルモンと臨床 2004; 52: 43-53. |
| 456 ） | 角田一男，渡辺哲子，三沢誠一，宗像正徳，佐久間博道，南尚義，上月正博，尾股健，今井潤，阿部圭志：アルドステロン産生腺腫手術後の長期予後-90例，術後平均経過年数11年の検討-．脈管学 1993; 33: 149-153. |
| 457 ） | Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenaga T, Kimura G: Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 1999; 33: 261-266. |
| 458 ） | 宮地幸隆：厚生科学研究費補助金特定疾患対策研究事業「副腎ホルモン産生異常に関する研究班」 平成13年度研究報告書． |
| 459 ） | Shenker Y: Medical treatment of low-renin aldosteronism. Endocrin Metab Clin North Am 1989; 18: 415-442. |
| 460 ） | Celen O, O'Brien MJ, Melby JC, Beazly RM: Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 1996; 131: 646-650. |
| 461 ） | Kaplan NM: Primary aldosteronism. In: Clinical Hypertension（7th ed.）, Williams & Wilkins, Baltimore, 1998, pp365-382. |
| 462 ） | 横山豊治，島本和明，飯村攻：本態性高血圧患者および原発性アルドステロン症患者におけるCa2+拮抗薬のアルドステロン分泌抑制機序に関する検討．日内分泌会誌 1995; 71: 1059-1074. |
| 463 ） | 三浦幸雄：原発性アルドステロン症．内科学（第6版）．杉本恒明，小俣政男（総編集），朝倉書店，東京，1995, pp1462-1468. |
| 464 ） | 尾股健，佐藤龍行，村上治，阿部圭志，笹野公伸：コルチゾール分泌を伴った原発性アルドステロン症の症例．治療学 1994; 28: 1397-1400. |
| 465 ） | 宮森勇：原発性アルドステロン症の症例．厚生省特定疾患「副腎ホルモン産生異常症」調査研究班 平成7年度研究報告書，1996, pp227-233. |
| 466 ） | Young S-C, Shionoiri H, Takasaki I, Kihara M, Gotoh E: Hypertensive complications in patients with primary aldosteronism. A retrospective study. Curr Ther Res 1991; 50: 317-325. |
| 467 ） | 名和田新：クッシング症候群（副腎性）．厚生省特定疾患「副腎ホルモン産生異常症」調査研究班 平成7年度研究報告書，1996, pp234-240. |
| 468 ） | 名和田新，出村 博，須田俊宏，高柳涼一：副腎性preclinical Cushing症候群．厚生省特定疾患「副腎ホルモン産生異常症」調査研究班 平成7年度研究報告書，1996, pp223-236. |
| 469 ） | 厚生省特定疾患「間脳下垂体機能障害」調査研究班 平成五年度研究報告書，1994, pp237-322. |
| 470 ） | 中尾一和：褐色細胞腫．厚生省特定疾患「副腎ホルモン産生異常症」調査研究班 平成7年度研究報告書，1996, pp257-259. |
| 471 ） | Miura Y, Yoshinaga K: Doxazosin: A newly developed, selective α1-inhibitor in the management of patients with pheochromocytoma. Am Heart J 1988; 116: 1785-1789. |
| 472 ） | 吉永馨，三浦幸雄，真山亨，盛英機，大沼徹太郎，三浦章男，杉野信博，三輪梅夫，小林正，渡辺泱，吉矢生人，沢山俊民，柊山幸志郎：メチル酸ドキサゾシンによる褐色細胞腫の治療．診療と新薬 1988; 25: 1367-1390. |
| 473 ） | Kaplan NM: Pheochromocytoma（with a preface about incidental adrenal masses）. In: Clinical Hypertension（7th ed.）, Williams & Wilkins, Baltimore, 1998, pp345-363. |
| 474 ） | Plouin PF, Chatellier G, Fofol I, Corvol P: Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension 1997; 292: 1133-1139. |
| 475 ） | Noshiro T, Honma H, Shimizu K, Kusakari T, Watanabe T, Akama H, Shibukawa S, Miura W, Abe K, Miura Y: Two cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine and dacarbazine in a combined chemotherapy. Endocr J 1996; 43: 279-284. |
| 476 ） | Saito I, Ito K, Saruta T: The effect of age on blood pressure in hyperthyroidism. J Am Geriatr Soc 1985; 33: 19-22. |
| 477 ） | Ogihara T, Hata T, Maruyama A, Mikami H, Nakamura M, Naka T, Kumahara Y, Kuma K: Blood Pressure response to an angiotensin II antagonist in thyrotoxic patients with and without high blood pressure. Endocrinol Jpn 1980; 27: 223-227. |
| 478 ） | Saito I, Ito K, Saruta T: Hypothyroidism as a cause of hypertension. Hypertension 1983; 5: 112-115. |
| 479 ） | Brickman AS, Nyby MD: Parathyroid disease and hypertension. In: Hypertension: Pathophysiology, diagnosis, and Management.（2nd ed.）, edited by Laragh JH, Brenner BM, Raven Press, New York, 1995, pp2263-2279. |
| 480 ） | Kaplan NM: Other forms of secondary hypertension. In: Clinical Hypertension.（7th ed.）,Williams & Wilkins, Baltimore, 1998, pp396-406. |
| 481 ） | 石川嘉市郎：高安病高血圧．領域別症候群シリーズ12 循環器症候群（日本臨床別冊）．1996, pp118-121. |
| 482 ） | 橋本博史：厚生省特定疾患免疫疾患調査研究班「難治性血管炎分科会」平成13年度研究報告書，2002，pp21-25. |
| 483 ） | 小出桂三：大動脈炎症候群の疫学調査：新規発症患者数と合併症について．厚生省特定疾患難治性血管炎研究班 1994年度研究報告書，1994, pp7-10. |
| 484 ） | 町田政久，佐久間まこと，青木秀俊，安田慶秀：高安動脈炎に合併した心大血管病変の長期遠隔成績．厚生省特定疾患難治性血管炎研究班 1993年度研究報告書 1993, pp192-195. |
| 485 ） | Miyata T, Sato O, Koyama H, Shigematsu H, Tada Y: Long-term survival after surgical treatment of patients with Takayasu's arteritis. Circulation 2003; 108: 1474-1480. |
| 486 ） | 厚生省保健医療局疾病対策課（監修）：結節性動脈周囲炎．難病の診断と治療指針．六法出版社，愛知，1997, pp107-115. |
| 487 ） | Tolo-Salgar OH, Steinberger J, Thomas W, Rocchini AP, Carpenter B, Moller JH: Long-term follow-up of patients after coarctation of the aorta repair. Am J Cardiol 2002; 89: 541-547. |
| 488 ） | Ross RD, Clapp SK, Gunther S, Paridon SH, Humes RA, Farooki ZQ, Pinsky WW: Augmented norepinephrine and renin output in response to maximal exercise in hypertensive coarctectomy patients. Am Heart J 1992; 123: 1293-1299. |
| 489 ） | Bell GM: Intracranial disorders and hypertension. In: Hypertension: Pathophysiology, diagnosis and management（2nd ed.）. Edited by Laragh JH, Brenner BM, Raven Press, New York, 1995, pp2451-2458. |
| 490 ） | Morimoto S, Sasaki S, Takeda K, Furuya S, Naruse S, Matsumoto K, Higuchi T, Saito M, Nakagawa M: Decrease in blood pressure and sympathetic nerve activity by microvascular decompression of the rostral ventrolateral medula in essential hypertension. Stroke 1999; 30: 1707-1710. |
| 491 ） | Johnson AG, Nguyen TV, Day RO: Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 121: 289-300. |
| 492 ） | Phillips BB, Joss JD, Mulhausen PL: Blood pressure elevation in a patients treated with salsalate. Ann Pharmacother 2002; 36: 624-627. |
| 493 ） | Whelton A: Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999; 106（5B）: S13-S24. |
| 494 ） | Fowles RE: Potential cardiovascular effects of COX-2 selective nonsteroidal anti-inflammatory drugs. J Pain Palliat Care Pharmacother 2003; 17: 27-50. |
| 495 ） | Sigurjonsdottir HA, Franzson L, Manhem K, Ragnarsson J, Sigurdsson G, Wallerstedt S: Liquorice-induced rise in blood pressure: a linear dose-response relationship. J Hum Hypertens 2001; 15: 549-552. |
| 496 ） | Sigurjonsdottir HA, Manhem K, Axelson M, Wallerstedt S: Subjects with essential hypertension are more sensitive to the inhibition of 11 β-HSD by liquorice. J Hum Hypertens 2003; 17: 125-131. |
| 497 ） | Sato A, Funder JW, Okubo M, Kubota E, Saruta T: Glucocorticoid-induced hypertension in the elderly. Relation to serum calcium and family history of essential hypertension. Am J Hypertens 1995; 8: 823-828. |
| 498 ） | Whitworth JA, Mangos GJ, Kelly JJ: Cushing, cortisol, and cardiovascular disease. Hypertension 2000; 36: 912-916. |
| 499 ） | Saruta T: Mechanism of glucocorticoid-induced hypertension. Hypertens Res 1996; 19: 1-8. |
| 500 ） | Whitworth JA, Schyvens CG, Zhang Y, Andrews MC, Mangos GL, Kelly JJ: The nitric oxide system in glucocorticoid-induced hypertension. J Hypertens 2002; 20: 1035-1043. |
| 501 ） | Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T: Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003; 92: 81-87. |
| 502 ） | Pirpiris M, Sudhir K, Yeung S, Jennings G, Whitworth JA: Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension 1992; 19: 567-574. |
| 503 ） | Luke RG: Mechanism of cyclosporine-induced hypertension. Am J Hypertens 1991; 4: 468-471. |
| 504 ） | 鈴木正司，合屋忠信：EPO使用基準のガイドライン作成の調査．平成4年度厚生科学研究腎不全医療研究事業研究報告書，1993, pp165-172. |
| 505 ） | Miyashita K, Tojo A, Kimura K, Goto A, Omata M, Nishiyama K, Fujita T: Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients. Hypertens Res 2004; 27: 79-84. |
| 506 ） | Kuriyama S, Hopp L, Yoshida H, Hikita M, Tomonari H, Hashimoto T, Sakai O: Evidence for amelioration of endothelial cell dysfunction by erythropoietin therapy in predialysis patients. Am J Hypertens 1996; 9: 426-431. |
| 507 ） | Ishimitsu T, Tsukada H, Ogawa Y, Numabe A, Yagi S: Genetic predisposition to hypertension facilitates blood pressure elevation in hemodialysis patients treated with erythropoietin. Am J Med 1993; 94: 401-406. |
| 508 ） | Hui KK: Hypertensive crisis induced by interaction of clonidine with imipramine. J Am Geriatr Soc 1983; 31: 164-165. |
| 509 ） | Abo-Zena RA, Bobek MB, Dweik RA: Hypertensive urgency induced by an interaction of mirtazapine and clonidine. Pharmacotherapy 2000; 20: 476-478. |
